AGP Executive Report

Diabetes Breakthrough: CagriSema (cagrilintide + semaglutide) cut HbA1c and body weight across REIMAGINE phase 3 trials, pointing to a next-gen combo for type 2 diabetes. Opioid-Use Disorder Research: NIH began the first randomized, placebo-controlled Phase I trial of purified mitragynine (MG001) for opioid use disorder, moving kratom science into FDA-regulated testing. Public Health Tech: With vaccine trust slipping, Penn Engineering says AI chatbots can match traditional materials in tackling vaccine hesitancy, based on JAMA Network Open findings. AI Safety & Reliability: A new push argues AI must be treated as fallible in high-stakes work, stressing human verification and limits of confident outputs. Space & Biomanufacturing: NASA named the Artemis III crew, while UC San Diego explored using plants to produce plant-virus-based pharmaceuticals under space-like conditions. Industry & Infrastructure: Ingredion agreed to buy Tate & Lyle for about $5B, and Hubbell completed its NSI Industries acquisition to expand electrical components. STEM & Skills: Bulgaria’s dual education forum highlighted shortages in engineering and tech roles, while Southern Arkansas University launched a B.S. in Emergency Management for Fall 2026.

Biotech & Pharma Deals: GSK is buying Nuvalent for $10.6B to expand its targeted lung cancer pipeline, a major oncology bet for its new CEO. Clinical Innovation: Life Biosciences dosed the first patient in its Phase 1 ER‑100 epigenetic restoration trial for optic neuropathies, while Treos Bio shared long-term MSS metastatic colorectal cancer results tied to its PEPI platform. Public Health & Vaccines: UMD researchers reported early trial safety for a dual Lassa fever/rabies vaccine, and new Ebola vaccine work continues to push toward broader protection. Medical Tech Markets: Reports project smart medical devices hitting $132.1B by 2031 and medical device affairs outsourcing reaching $8.1B by 2031, reflecting growing regulatory and connected-care demand. Preclinical Testing Shift: ADME toxicology testing is forecast to nearly double to $17.48B by 2035 as regulators lean on in vitro and in silico methods. AI in Biomed: A collaboration aims to build an AI-enabled multi-omics platform for NF1 patient stratification and biomarker discovery. Tech & Industry: KBR won a $95M digital engineering contract for the US Space Force, and Helionis Labs raised pre-seed funding to tackle thermal management for high-power electronics.

AI Energy Breakthrough: UMass Amherst researchers unveiled a brain-inspired AI framework aimed at cutting energy use while keeping performance, pushing toward more scalable, embedded AI. Behavioral Health: A large wearable-based study finds a fast, bidirectional loop between light movement and mood boosts, while an ED “nudge” approach increases naltrexone prescriptions for alcohol use disorder. Precision Medicine & Biotech: A disease-focused vision-language AI model targets kidney cancer, and Sniffles2 improves structural variant detection from long-read sequencing. Public Health & Pharma: Phase 3 data support once-weekly oral HIV therapy, and survodutide trials report major visceral and liver fat reductions. Medical Research: New work links hyperoxia to bronchopulmonary dysplasia mechanisms, and studies explore exercise’s effects on older adults’ executive function. Biosecurity: USDA confirmed additional New World screwworm cases, including one in New Mexico, as containment efforts continue.

AI Infrastructure & Power Demand: Texas’ grid operator ERCOT says data-center connection requests have surged, with developers eyeing massive new loads for AI compute—raising reliability and planning pressure. Semiconductors & “AI Factories”: Korea is pushing Nvidia’s GPU and physical-AI rollout, while Nvidia and LG unveil an “AI factory” push for autonomous vehicles and robotics. Research Breakthroughs: Los Alamos researchers say they’ve completed a mathematical framework for how humans perceive colour, and ancient DNA work helped propose an identity for a 300-year-old colonial burial. Biotech & Drug Updates: ADA-focused obesity and diabetes pipeline news continues, including new Phase 3/clinical updates around GLP-1-style therapies and other metabolic candidates. STEM Pathways: Qatar’s MoEHE will let arts-track students bridge into STEM majors, and IIT Mandi adds new BTech options spanning quantum and data analytics. Science Policy & Trust: Coverage highlights renewed pressure on US science funding and editorial independence amid political interference concerns. Education & Community Science: From rocket-building teams to school science lessons and medical screenings, hands-on tech learning keeps showing up worldwide.

Federal Education Policy: Trump’s “One Big Beautiful Bill” tightens federal student loan caps for graduate and professional schools, including a $50,000/year limit for law and medical programs and a $257,000 lifetime cap, with UCLA warning summer loan processing delays. Climate Watch: The UN’s World Meteorological Organization confirms El Niño is back, with Pacific heat running far above average and fears of a “super El Niño” driving extreme weather. Medical Breakthroughs: Extended-release febuxostat beats standard for chronic gout urate control; new GLP-1 and related obesity data keep rolling in, including ecnoglutide’s head-to-head weight-loss edge and monthly GLP-1 efforts; a gut-microbe study links indoles to anxiety regulation, pointing to next-gen probiotics. Diabetes Tech: Diasome’s HDV-insulin lispro maintains glycemic control while reducing severe hypoglycemia, and real-world Huntington data suggest deutetrabenazine may improve quality of life. Alzheimer’s Research: Scientists map microglia state transitions that may explain why some people stay cognitively resilient despite Alzheimer’s pathology. Space & Materials: China advances “space power bank” wireless energy tests, while Argonne researchers tailor MXenes at near-atomic precision for future electronics. Health & Safety: Australia’s top neurologists accuse the regulator of ignoring concerns over paraquat’s Parkinson’s risk. Science in the Wild: A Brazilian expedition confirms 2+ dozen new marine species in days using shipboard imaging and sequencing.

Universal vaccine breakthrough: Cambridge and DIOSynVax say an AI-designed “super-antigen” coronavirus vaccine cleared its first human trial in 39 volunteers, aiming for broad protection across sarbecoviruses and future mutations. Public health tech: The ADA’s 2026 Innovation Challenge named Adaptyx Biosciences, Nymble Health, and Silverstream Medical for wearable and AI-driven diabetes care tools. Medical devices: Researchers report an ultrasound-based “pacemaker” concept using sonogenetics to noninvasively steady heart activity. Healthcare policy & regulation: Nova Scotia moves to regulate naturopathic doctors, while the EU unveils a roadmap to phase out animal testing in chemical safety reviews. AI in education and jobs: Bangladesh pushes mandatory internships and stronger industry-academia links to cut graduate unemployment. STEM capacity building: Ghana’s flagship Abomosu STEM school faces growing pains—staffing, funding, maintenance, and industry partnerships. Environment & health risks: A new $3.3M study will test whether microplastics accumulate in the body and harm the cardiovascular system. Energy and industry: India accelerates coal gasification as a bridge fuel amid LNG shortages, despite higher emissions trade-offs. Space strategy: The Philippines backs new satellite programs to boost sovereign Earth observation and secure geostationary communications.

DNA & Forensics: New York’s annual Missing Persons Day, run by the OCME, brings families to forensic biologists to push cold-case identifications using DNA—an effort the city says has already produced 100+ matches. Public Health Threat: Texas officials and the USDA are racing to respond to the New World screwworm fly after fresh detections, with a sterile-fly facility delayed beyond a year. Biotech Breakthroughs: Researchers report the first highly precise DNA editing in human embryos, reigniting germline debate; separately, a portable CRISPR test is highlighted for Mpox detection in the field. Regenerative Medicine: The University of Miami opens a 3D bioprinting lab aimed at living tissue, bone, and faster wound-healing approaches. AI + Industry: Intel’s AI bootcamp trains students for real-world projects, while reports say Bitcoin miners are pivoting into AI data centers. Climate Science: New work uses lake mud records to refine how soot darkened Arctic snow and sped melting.

AI Safety Debate: Anthropic co-founder Jack Clark says the AI industry is accelerating “without a brake pedal,” warning that self-improving systems could outpace human oversight. Ocean Forecasting: China’s CAS unveiled LangYa 2.0, an upgraded ocean forecasting AI aimed at predicting typhoons, storm surges, and other complex marine events for disaster planning and shipping. Biotech for Food Security: Nigeria’s experts urged urgent investment in biotechnology to strengthen food security, healthcare resilience, and jobs, highlighting a national push to turn bioresources into innovation. Traditional Medicine R&D: China and Pakistan launched a Zhejiang-Pakistan joint herbal medicine lab, building a formal research pipeline across universities and hospitals. Cancer Diagnostics: India reported a blood-based protein signature that may flag lung cancer risk more than five years early, positioning it as a risk tool for earlier monitoring. Education & Skills: Russia’s TMK at SPIEF backed faster university-industry collaboration through legal and institutional support, while India’s KCET results confirmed engineering eligibility for admissions at scale. Public Health Misinformation: Canada’s medical journal update reassures that acetaminophen (Tylenol) is safe in pregnancy when used as directed, countering earlier unsupported warnings. Medical Tech Innovation: Researchers described a portable point-of-care PET system designed to bring real-time molecular imaging to interventional radiology.

Biotech Breakthrough: Utah State University researchers say a new CRISPR tool inspired by cave bacteria (Cas12a2) can selectively target and shred DNA in cancer cells, pointing to fresh gene-editing cancer strategies. Cancer Drug Mechanism Rethink: Baylor researchers challenge the idea that HDAC inhibitors work only by blocking HDAC enzymes, arguing they may hit other pathways—an important step toward better targeted therapies. Addiction Neurobiology: A Q&A highlights preclinical work on GATC-1021, designed to modulate serotonin receptors to reduce fentanyl intake and boost brain plasticity markers, aiming for new opioid use disorder options. Gene Editing Ethics: Columbia scientists report highly precise base editing in early human embryos, sparking renewed debate over disease repair versus trait selection. AI Safety Debate: Anthropic calls for a global pause on frontier AI development, warning about recursive self-improvement risks and the need for coordinated “brake pedal” safeguards. Energy & Industry: DOE and Japan launch a $1B Genesis Mission research partnership spanning quantum, fusion, biotech, materials, particle physics, and autonomous labs. Nuclear Expansion: Uzbekistan issues a construction license for a nuclear unit using an RITM-200N reactor, with IAEA-aligned safety review. Health Tech & Care: University of Miami opens a $5M 3D bioprinting lab for regenerative medicine, drug development, and patient-specific models. Wildlife & Climate: Studies report endangered Hawaiian false killer whales are losing hundreds of pounds fast, while deep-ocean trenches reveal dense life on bare rock. Policy & Public Health: A JAMA study finds maternal RSV vaccination during pregnancy cuts infant RSV hospitalizations by nearly 70%.

AI in Biomed: Cambridge researchers say an AI-designed “super-antigen” vaccine could target whole virus families, with a human trial already showing safety and a phase II push underway. Space & Defense Tech: MIT engineers tested a small-satellite hybrid propulsion approach that pairs chemical thrust with efficient electric propulsion using the same fuel—aimed at faster Mars-class missions. Climate & Ocean Monitoring: Scientists warn that dismantling a key US ocean observation system would leave the world “flying blind,” degrading storm and El Niño forecasting. Big Science via AI: Japan becomes the first international partner in the US “Genesis Mission,” a government-backed AI science push spanning quantum, fusion, semiconductors, biotech, and materials. Energy Transition: Cambodia’s garment industry could gain from decarbonization pressure, leveraging a relatively clean grid and renewables to attract low-carbon manufacturing investment. Health Policy: Radiologists and other researchers are alarmed by proposed US federal grant rule changes that could add compliance burdens and politicize funding decisions. Agritech & Food Systems: China identified a high-protein gene in wild corn to boost feed protein and reduce reliance on imports. Environment & Health: A new study-backed myth-buster says there’s no need to wait 30 minutes after eating before swimming.

Data Center Clash: Utah Senate President Stuart Adams secured major concessions from Kevin O’Leary’s Stratos Hyperscale plan, including a proposed 75% footprint cut and tighter water and conservation commitments tied to Great Salt Lake protections. FDA Biotech: Lupin won U.S. FDA approval for Ranluspec (ranibizumab-hkdz) as an interchangeable biosimilar to Lucentis. Fusion Funding: Helion raised $465M, lifting total funding to $1.5B and signaling surging investor appetite for grid-scale fusion power. Microplastics Science: A first human study reports Qi601 postbiotic can bind microplastics and keep about 98% associated through digestion. Physical AI for Driving: HKUST and CalmCar launched an “Physical AI Innovation Center” to improve real-world reliability for autonomous driving and robotics. Medical Devices: MIT unveiled an ultrasound “sticker” pacemaker concept that corrected arrhythmias in rats without surgery. Energy Storage: Industry discussion is reviving semi-solid-state batteries as all-solid-state timelines slip. STEM Education: Southern Miss plans a $87.5M, 93,000-square-foot science facility for biotech and public health research.

Neurotech Commercial Push: Control Bionics says its muscle-signal NeuroNode assistive communication device is gaining traction in the US as states covering ~70% of the population fund it via the E2513 reimbursement pathway, supporting major distribution deals. Cosmic Mapping Breakthrough: CSIRO and the SKA Observatory team released SPICE-RACS, a five-times-larger radio map of the Universe’s magnetic fields built from signals from nearly four million galaxies. HIV Prevention Rollout: South Africa’s public clinics begin offering a six-month lenacapavir injection for HIV prevention, a major step amid ongoing high infection rates and rollout capacity concerns. Biotech Funding for Materials: Dutch startup New Dawn Bio raised €2.1M to grow deforestation-free wood in bioreactors using tree cells. AI in Industry: Quantinuum and Mitsubishi Electric signed an MOU to test quantum and hybrid computing for engineering simulation and design workloads. Public Health Tooling: A pictogram-based shared decision aid (HCQ-SAFE) improved hydroxychloroquine adherence in lupus patients in about five minutes per visit. Energy Policy Shock: Reuters reports India’s tougher grid rules for solar and wind could cut returns and chill investment as the country races toward clean capacity targets.

Healthcare Tech & Safety: A new critique of the NHS “single patient record” warns that the goal is right but the design risks category mistakes that could confuse clinicians and patients at the worst moments. Medical Fraud: A Brooklyn clinic owner was convicted in federal court over a $52M Medicare/Medicaid drug diversion scheme tied to sham Suboxone prescriptions and kickbacks. Clinical Guidance: The Society for Maternal-Fetal Medicine reaffirmed acetaminophen (Tylenol) as first-line for pain and fever in pregnancy, pushing back on politicized claims. Biotech & Pharma Manufacturing: Shilpa Biocare and Gate2Brain struck an equity deal to advance a brain-cancer peptide-shuttle therapy; Aurobindo opened TheraNym, a large biologics contract manufacturing site in Telangana; Akums won an EU CEP for cefpodoxime Proxetil. AI in Hospitals: Shyld AI will demo action-based infection prevention agents using UV-C disinfection and workflow intelligence at APIC 2026. Quantum & Computing: Microsoft cut its quantum timeline in half, aiming for 2029. Policy & Research Infrastructure: The US plans to dismantle the Ocean Observatories Initiative, raising alarms for marine monitoring and disaster readiness. Education & Workforce: Los Angeles Rams and Hollywood Park wrapped year one of a STEAM program, with plans to expand into high schools.

Neurotech: China has approved an invasive brain-computer interface for clinical use beyond trials, marking a major step toward regulated neurotechnology deployment after early patient rehabilitation results. AI for work: Microsoft used Build to expand “agentic” Copilot capabilities, add an agent context layer across developer and enterprise tools, and push new prototypes for AI workflows. Healthcare devices: UC San Diego and Oxford reported an adhesive ultrasound patch for continuous fetal monitoring, aiming to improve access to high-risk pregnancy surveillance outside specialist settings. Biotech R&D: Ingenix raised €13m to scale its modality-fusion AI engine for drug development, targeting better reasoning across diverse biological data types. Energy & climate: Pure Data Centres completed Europe’s first large-scale cross-border biomethane purchase for a data centre, showing operational decarbonisation at scale. Space & computing: Beijing approved a space computing industry innovation center to connect the satellite computing supply chain and boost space-native chip and payload development. Public health policy: South Africa moved to allow HPAI vaccinations, shifting away from mass culling as bird flu control strategy. Materials & medicine: China’s “Bone 02” bone adhesive won innovation recognition from both Chinese and U.S. regulators, aiming to bond fractures in wet surgical conditions.

AI Policy Fight: Bernie Sanders proposes an “AI Sovereign Wealth Fund,” funded by a one-time 50% tax on major AI company stock, aiming to give the public direct ownership. Neonatal Care & Drug Safety: Researchers report citrate-functionalized manganese oxide nanoparticles as a potential phase 1 option for newborns at risk of acute bilirubin encephalopathy, while another study weighs brief intensive phototherapy for jaundice. Health Tech & Pharma: Microsoft’s Discovery platform goes generally available with Ginkgo Bioworks, pushing agentic AI from hypothesis to lab execution; meanwhile, a JAMA Network Open cohort links statin timing to survival in early breast cancer subtypes. Biotech & Ethics: Gladstone launches the Center for PhAIge Therapy to scale phage treatments for antibiotic-resistant infections, and “artificial womb” research keeps raising hard ethical questions. Climate Science: WMO warns a strong El Niño is likely, with climate change amplifying the extremes. Energy & Materials: IIT Gandhinagar details an adaptive EV battery charging method to reduce lithium plating, and new work targets waste-heat-to-power on chips.

Advanced Materials Collaboration: TACC (LNJ Bhilwara Group) signed an MoU with NUS’s I-FIM to speed up research, testing, validation and commercialization of graphene and other functional nanomaterials. Industrial Imaging Hardware: Vadzo Imaging launched the VAJRA-900MGS, a 3MP monochrome global-shutter USB 3.2 Gen 2x2 UVC camera built on Sony’s IMX900 and Infineon’s FX20, aimed at high-speed automation and robotics. Solar Grid Reliability: TERI convened stakeholders on firm dispatchable renewables, focusing on concentrated solar power with thermal energy storage for India’s clean-energy transition. AI in Consumer Tech: ByteDance’s AI research leader Gu Quanquan left the company as it pushes monetization of Doubao and its Seed models. Healthcare Tech & Trials: Crinetics will present new ENDO 2026 data on PALSONIFY for acromegaly and atumelnant for ACTH-excess conditions. Biotech Pipeline Momentum: CorrectSequence reported 15-month follow-up showing a sickle-cell patient remains free of vaso-occlusive crises after base-editing CS-206. EU Climate Accounting: The European Commission’s CountEmissionsEU standardized method for transport emissions entered into force to make reporting comparable across modes. Ebola Vaccine Race: Three groups are working in parallel on Ebola vaccines targeting a fast-moving Bundibugyo outbreak in Congo.